Advertisement

The Impact of Roux-en-Y Gastric Bypass on Bone Remodeling Expressed by the P1NP/βCTX Ratio: a Single-Center Prospective Cohort Study

  • Markus K. Muller
  • Daniel Gero
  • Daniela Reitnauer
  • Diana Vetter
  • Dilmurodjon Eshmuminov
  • Thorsten Hornemann
  • Marco BueterEmail author
Original Contribution
  • 29 Downloads

Abstract

Background

Bariatric surgery seems to decrease bone mineral density and increase the risk of fatigue fractures. P1NP (bone formation) and βCTX (bone resorption) were recently validated as reference bone turnover markers (BTM).

Objective

To assess changes in bone remodeling in severely obese patients undergoing Roux-en-Y gastric bypass (RYGB) by using a new composite biomarker, the P1NP/βCTX ratio.

Methods

We prospectively collected blood samples preoperatively, at 1 month and at 1 year from 114 consecutive RYGB patients from 12/2012 to 04/2014. Repeated measures ANOVA and multiple regression were used for data analysis. Cumulative incidence of fractures was assessed in 06/2018.

Results

The P1NP/βCTX ratio decreased significantly (P < 0.001) from baseline to 1 month and 1 year (180 ± 6.6, 110 ± 4.1, and 132 ± 5.4). The 1-year P1NP/βCTX ratio did not correlate with BMI or ΔBMI, but inversely correlated with age (r = − 0.23, P = 0.014) and with hsCRP (r = − 0.26, P = 0.009), even after adjustment for age, sex, BMI, and lifestyle, and linearly correlated with albumin (r = 0.2, P = 0.037). At baseline, none of these correlations were detectable. Serum for all time-points was available from > 94% of the patients. At a median follow-up of 4.7 years, 8 patients (7.3%) had a bone fracture, all of them traumatic.

Conclusion

Following RYGB, bone remodeling increases, with a shift toward degradation. This effect seems to be weight-loss independent and shows a correlation with age, with the level of systemic inflammation, and with nutritional state. The risk of fractures should be assessed systematically in bariatric patients and measures of prevention should be improved accordingly.

Keywords

Bone remodeling Roux-en-Y gastric bypass Parathyroid hormone P1NP/βCTX ratio Bone turnover markers Vitamin D Systemic inflammation 

Notes

Acknowledgements

We are grateful to Lilian Roth, MD, for her help in the data collection process.

Communication

The Best Oral Presentation Prize was awarded to Daniel Gero for presenting this study at the 8th International Federation of Surgery of Obesity – European Chapter meeting in Athens, Greece on 19th May 2018.

Funding

The study was entirely funded by the assistant-professorship research grant awarded by the University of Zurich to Prof. Dr. med. Marco Bueter, PhD.

Compliance with Ethical Standards

Ethical Approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and cantonal research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed Consent

All enrolled patients provided written informed consent for voluntary participation in the study and to de-identified use of their health-related data for scientific purposes.

Conflict of Interest

The authors declare that they have no conflict of interest.

Supplementary material

11695_2018_3640_MOESM1_ESM.pdf (280 kb)
ESM 1. Receiver Operating Characteristic curves to assess positive and negative predictive values of the burn turnover markers to predict a fracture after RYGB. A. P1NP at baseline (P = 0.379) and at 1-year (P = 0.02, AUC = 0.75, threshold = 80.4 ng/ml, specificity = 0.63, sensitivity = 0.88), B. ßCTX at baseline (P = 0.519) and at 1-year (P = 0.255), C. P1NP/ ßCTX at baseline (P = 0.041) and at 1-year (P = 0.159). (PDF 280 kb)

References

  1. 1.
    Cuschieri S, Vassallo J, Calleja N, et al. The diabesity health economic crisis-the size of the crisis in a European island state following a cross-sectional study. Arch Public Health. 2016;74:52.CrossRefGoogle Scholar
  2. 2.
    Tian L, Yu X. Fat, sugar, and bone health: a complex relationship. Nutrients. 2017;9(5).  https://doi.org/10.3390/nu9050506.
  3. 3.
    Shapses SA, Pop LC, Wang Y. Obesity is a concern for bone health with aging. Nutr Res. 2017;39:1–13.CrossRefGoogle Scholar
  4. 4.
    Soleymani T, Tejavanija S, Morgan S. Obesity, bariatric surgery, and bone. Curr Opin Rheumatol. 2011;23:396–405.CrossRefGoogle Scholar
  5. 5.
    Pirila S, Taskinen M, Turanlahti M, et al. Bone health and risk factors of cardiovascular disease--a cross-sectional study in healthy young adults. PLoS One. 2014;9:e108040.CrossRefGoogle Scholar
  6. 6.
    Harper C, Pattinson AL, Fernando HA, et al. Effects of obesity treatments on bone mineral density, bone turnover and fracture risk in adults with overweight or obesity. Horm Mol Biol Clin Investig. 2016;28:133–49.Google Scholar
  7. 7.
    Rousseau C, Jean S, Gamache P, et al. Change in fracture risk and fracture pattern after bariatric surgery: nested case-control study. BMJ. 2016;354:i3794.CrossRefGoogle Scholar
  8. 8.
    Fashandi AZ, Mehaffey JH, Hawkins RB, et al. Bariatric surgery increases risk of bone fracture. Surg Endosc. 2018;32:2650–5.CrossRefGoogle Scholar
  9. 9.
    Folli F, Sabowitz BN, Schwesinger W, et al. Bariatric surgery and bone disease: from clinical perspective to molecular insights. Int J Obes. 2012;36:1373–9.CrossRefGoogle Scholar
  10. 10.
    Gregory NS. The effects of bariatric surgery on bone metabolism. Endocrinol Metab Clin N Am. 2017;46:105–16.CrossRefGoogle Scholar
  11. 11.
    Yu EW, Wewalka M, Ding SA, et al. Effects of gastric bypass and gastric banding on bone remodeling in obese patients with type 2 diabetes. J Clin Endocrinol Metab. 2016;101:714–22.CrossRefGoogle Scholar
  12. 12.
    Lenchik L, Register TC, Hsu FC, et al. Adiponectin as a novel determinant of bone mineral density and visceral fat. Bone. 2003;33:646–51.CrossRefGoogle Scholar
  13. 13.
    Muller-Stich BP, Senft JD, Warschkow R, et al. Surgical versus medical treatment of type 2 diabetes mellitus in nonseverely obese patients: a systematic review and meta-analysis. Ann Surg. 2015;261:421–9.CrossRefGoogle Scholar
  14. 14.
    Fisher A, Srikusalanukul W, Fisher L, et al. Lower serum P1NP/betaCTX ratio and hypoalbuminemia are independently associated with osteoporotic nonvertebral fractures in older adults. Clin Interv Aging. 2017;12:1131–40.CrossRefGoogle Scholar
  15. 15.
    Spadola CE, Wagner EF, Dillon FR, et al. Alcohol and drug use among postoperative bariatric patients: a systematic review of the emerging research and its implications. Alcohol Clin Exp Res. 2015;39:1582–601.CrossRefGoogle Scholar
  16. 16.
    Moser F, Signorini FJ, Maldonado PS, et al. Relationship between tobacco use and weight loss after bariatric surgery. Obes Surg. 2016;26:1777–81.CrossRefGoogle Scholar
  17. 17.
    Zabatiero J, Smith A, Hill K, et al. Do factors related to participation in physical activity change following restrictive bariatric surgery? Obes Res Clin Pract: A qualitative study; 2017.Google Scholar
  18. 18.
    Savvidis C, Tournis S. Dede AD. Hormones (Athens): Obesity and bone metabolism; 2018.Google Scholar
  19. 19.
    Vasikaran S, Eastell R, Bruyere O, et al. Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards. Osteoporos Int. 2011;22:391–420.CrossRefGoogle Scholar
  20. 20.
    von Elm E, Altman DG, Egger M, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet. 2007;370:1453–7.CrossRefGoogle Scholar
  21. 21.
    Weber M, Muller MK, Bucher T, et al. Laparoscopic gastric bypass is superior to laparoscopic gastric banding for treatment of morbid obesity. Ann Surg. 2004;240:975–82. discussion 82-3CrossRefGoogle Scholar
  22. 22.
    Yu EW, Carmody JS, Brooks DJ, et al. Cortical and trabecular deterioration in mouse models of roux-en-Y gastric bypass. Bone. 2016;85:23–8.CrossRefGoogle Scholar
  23. 23.
    Biagioni MFG, Mendes AL, Nogueira CR, et al. Bariatric Roux-En-Y gastric bypass surgery: adipocyte proteins involved in increased bone remodeling in humans. Obes Surg. 2017;27:1789–96.CrossRefGoogle Scholar
  24. 24.
    Ivaska KK, Huovinen V, Soinio M, et al. Changes in bone metabolism after bariatric surgery by gastric bypass or sleeve gastrectomy. Bone. 2017;95:47–54.CrossRefGoogle Scholar
  25. 25.
    Crawford MR, Pham N, Khan L, et al. Increased bone turnover in type 2 diabetes patients randomized to bariatric surgery versus medical therapy at 5 years. Endocr Pract. 2018;24:256–64.CrossRefGoogle Scholar
  26. 26.
    Bredella MA, Greenblatt LB, Eajazi A, et al. Effects of Roux-en-Y gastric bypass and sleeve gastrectomy on bone mineral density and marrow adipose tissue. Bone. 2017;95:85–90.CrossRefGoogle Scholar
  27. 27.
    Beamish AJ, Gronowitz E, Olbers T, et al. Body composition and bone health in adolescents after Roux-en-Y gastric bypass for severe obesity. Pediatr Obes. 2017;12:239–46.CrossRefGoogle Scholar
  28. 28.
    Muschitz C, Kocijan R, Marterer C, et al. Sclerostin levels and changes in bone metabolism after bariatric surgery. J Clin Endocrinol Metab. 2015;100:891–901.CrossRefGoogle Scholar
  29. 29.
    Costa TL, Paganotto M, Radominski RB, et al. Calcium metabolism, vitamin D and bone mineral density after bariatric surgery. Osteoporos Int. 2015;26:757–64.CrossRefGoogle Scholar
  30. 30.
    Biagioni MF, Mendes AL, Nogueira CR, et al. Weight-reducing gastroplasty with Roux-en-Y gastric bypass: impact on vitamin D status and bone remodeling markers. Metab Syndr Relat Disord. 2014;12:11–5.CrossRefGoogle Scholar
  31. 31.
    Court-Brown CM, Biant L, Bugler KE, et al. Changing epidemiology of adult fractures in Scotland. Scott Med J. 2014;59:30–4.CrossRefGoogle Scholar
  32. 32.
    Rathmann W, Kostev K. Fracture risk in patients with newly diagnosed type 2 diabetes: a retrospective database analysis in primary care. J Diabetes Complicat. 2015;29:766–70.CrossRefGoogle Scholar
  33. 33.
    Département fédéral de l‘intérieur Confédération suisse. Listes des analyses. Published by the Office fédéral de la santé publique, Bern; 1.1.2018.  https://www.bag.admin.ch/bag/fr/home/versicherungen/krankenversicherung/krankenversicherung-leistungen-tarife/Analysenliste.html.
  34. 34.
    Fisher A, Fisher L, Srikusalanukul W, et al. Bone turnover status: classification model and clinical implications. Int J Med Sci. 2018;15:323–38.CrossRefGoogle Scholar
  35. 35.
    Chakhtoura MT, Nakhoul N, Akl EA, et al. Guidelines on vitamin D replacement in bariatric surgery: identification and systematic appraisal. Metabolism. 2016;65:586–97.CrossRefGoogle Scholar
  36. 36.
    Muschitz C, Kocijan R, Haschka J, et al. The impact of vitamin D, calcium, protein supplementation, and physical exercise on bone metabolism after bariatric surgery: the BABS study. J Bone Miner Res. 2016;31:672–82.CrossRefGoogle Scholar
  37. 37.
    Cao JJ. Effects of obesity on bone metabolism. J Orthop Surg Res. 2011;6:30.CrossRefGoogle Scholar
  38. 38.
    Huang JV, Schooling CM. Inflammation and bone mineral density: a Mendelian randomization study. Sci Rep. 2017;7:8666.CrossRefGoogle Scholar
  39. 39.
    Xanthakos SA. Nutritional deficiencies in obesity and after bariatric surgery. Pediatr Clin N Am. 2009;56:1105–21.CrossRefGoogle Scholar
  40. 40.
    Schafer AL, Weaver CM, Black DM, et al. Intestinal calcium absorption decreases dramatically after gastric bypass surgery despite optimization of vitamin D status. J Bone Miner Res. 2015;30:1377–85.CrossRefGoogle Scholar
  41. 41.
    Sampson HW. Alcohol and other factors affecting osteoporosis risk in women. Alcohol Res Health. 2002;26:292–8.Google Scholar
  42. 42.
    Haskins IN, Amdur R, Vaziri K. The effect of smoking on bariatric surgical outcomes. Surg Endosc. 2014;28:3074–80.CrossRefGoogle Scholar
  43. 43.
    Aminian A. Sleeve gastrectomy: metabolic surgical procedure of choice? Trends Endocrinol Metab. 2018;29:531–4.CrossRefGoogle Scholar
  44. 44.
    Angrisani L, Santonicola A, Iovino P, et al. IFSO Worldwide Survey 2016 : Primary, Endoluminal, and Revisional procedures. Obes Surg. 2018;28:3783–94.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Department of SurgeryCantonal Hospital FrauenfeldFrauenfeldSwitzerland
  2. 2.Department of Surgery and TransplantationUniversity Hospital ZurichZurichSwitzerland
  3. 3.Institute of Clinical ChemistryUniversity and University Hospital of ZurichZurichSwitzerland

Personalised recommendations